19 Aug14:38 Business Novo Nordisk Tests Lower-Dose Wegovy Pill in 450-Patient Study Novo Nordisk has begun testing a lower-dose Wegovy pill in a 450-patient study, a pipeline move that could reshape GLP-1 pricing and competition. Keith Howard · 19 Aug